{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:29:17Z","timestamp":1787671757016,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacc.2026.06.006","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:40:15Z","timestamp":1787668815000},"page":"828-830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interpreting Contemporary PCI for Diabetes and Multivessel Coronary Disease After FREEDOM"],"prefix":"10.1016","volume":"88","author":[{"given":"Valent\u00edn","family":"Fuster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Vazirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jacc.2026.06.006_bib1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jacc.2026.05.025","article-title":"Ultra-thin sirolimus-eluting versus everolimus-eluting stents in diabetic multivessel coronary artery disease patients: the TUXEDO-2 trial","volume":"88","author":"Kaul","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.06.006_bib2","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacc.2026.06.006_bib3","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.06.006_bib4","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.06.006_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2018.11.001","article-title":"Long-term survival following multivessel revascularization in patients with diabetes: the FREEDOM follow-on study","volume":"73","author":"Farkouh","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.06.006_bib6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(18)32467-X","article-title":"Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial","volume":"393","author":"Zaman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2026.06.006_bib7","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.118.034456","article-title":"Newer-generation ultrathin strut drug-eluting stents versus older second-generation thicker strut drug-eluting stents for coronary artery disease: meta-analysis of randomized trials","volume":"138","author":"Bangalore","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.06.006_bib8","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJMoa1510188","article-title":"Paclitaxel-eluting versus everolimus-eluting coronary stents in diabetes","volume":"373","author":"Kaul","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.06.006_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(25)02157-9","article-title":"Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY diabetes global): results from a multicentre, randomised controlled trial","volume":"407","author":"Abizaid","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2026.06.006_bib10","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(25)00505-7","article-title":"Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial","volume":"405","author":"Fearon","year":"2025","journal-title":"Lancet"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109726067732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109726067732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:56:53Z","timestamp":1787669813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109726067732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0735109726067732"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2026.06.006","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interpreting Contemporary PCI for Diabetes and Multivessel Coronary Disease After FREEDOM","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2026.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2026.05.025","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}